Rodman & Renshaw Starts Ventrus Biosciences (VTUS) at Market Outperform
Tweet Send to a FriendGet Alerts VTUS Hot Sheet
Price: $2.21 --0%
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 19
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 19
Trade VTUS Now!
Rodman & Renshaw initiates coverage on Ventrus Biosciences (NASDAQ: VTUS) with a Market Outperform. PT $12.
For more ratings news on Ventrus Biosciences click here and for the rating history of Ventrus Biosciences click here.
Shares of Ventrus Biosciences closed at $6.14 yesterday, with a 52 week range of $5.75-$7.71.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Ventrus Biosciences click here and for the rating history of Ventrus Biosciences click here.
Shares of Ventrus Biosciences closed at $6.14 yesterday, with a 52 week range of $5.75-$7.71.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Oppenheimer Starts Carter's (CRI) at Perform
- Oppenheimer Starts The Children's Place (PLCE) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Rodman & Renshaw
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
